Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aging
Researchers at Rockefeller University target aging
April 6th, 2008
New investigation results, 'Behavioral and biological effects of chronic S18986, a positive AMPA receptor modulator, during aging,' are detailed in a study published in Experimental Neurology. "AMPA receptors are a major subtype of ionotropic receptors that respond to glutamate. Positive allosteric modulators of AMPA receptors selectively enhance fast excitatory neurotransmission in the brain and increase overall neuronal excitability," scientists writing in the journal Experimental Neurology report. "In addition to enhancing cognitive performance, S18986 (Servier, France) and other AMPA receptor modulators have also been shown to be neuroprotective. A...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-06)
|
